-
-
-
-
-
Regulatory : Manufacturing Chemist Live 2020: Call for papers
Breaking News
Ilya Pharma takes minibioreactor wound care biologic into the clinic
Swedish MPA approves first-in-human trial of Ilya Pharma’s first-in-class ILP100 topical wound care therapy
Kite to build plant for cell therapies portfolio in California
A 67,000-square-foot facility will be built within an existing Gilead biologics production site in Oceanside
Microphyt gets cash injection to boost sales network and production
French nutraceutical operates a patented process that solves the drawbacks of microalgae production
Industrial coatings company chooses ABB Ability to achieve zero downtime
Transcontinental Advanced Coatings has piloted ABB's system on equipment at its Wrexham facility
Nosopharm chooses Evotec to advance next-gen Odilorhabdin drug candidate
The initial focus is on chemistry and manufacturing and control (CMC) to bring NOSO-502 to clinical stage
The Native Antigen company signs global distribution agreements
The UK reagents specialist has named BIOZOL and Shanghai Bioleaf sole traders in Germany, Switzerland, Austria and ...
Preparing for the paradigm shift in bioprocessing
While upstream titers have improved dramatically over the last decade, downstream processing has remained relatively ...
Cherwell microbiology specialist examines trends in pharma
Hamish Hogg comments on GMP audit to aseptic processing and other hot topics as presented at the Pharmaceutical and ...
WHP completes cleanroom project for ADC Bio in the UK
The GMP facility in North Wales features Grade C and D cleanrooms and four-zone HVAC systems
Process optimisation with flow chemistry
WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more ...
Recombinant cultures for superior enzyme output
A non-GMP enzyme manufacturing process at Porton Biopharma has been converted from native production to recombinant ...
Nanonisation: Tiny technology to turn drug failures to success
Finnish biotech Nanoform opens up on the new process that is quickly catching on among drug developers and manufacturers
British cell and gene therapy accelerator releases annual report
The CGT Catapult has worked on more than 110 projects addressing industry challenges
UK government releases £125 million in grant funding to support innovators
The cash injection will see businesses turn ideas into new products and services on the market
In Brief
Most Popular
- Mile High Labs buys ex-Novartis site in Colorado to produce CBD products
- UK government releases £125 million in grant funding to support innovators
- Establishing a secure supply chain for phyto-APIs
- Boehringer Ingelheim acquires Swiss biotech company AMAL Therapeutics
- British cell and gene therapy accelerator releases annual report
People
- Cambrex makes three senior appointments
- Medherant appoints new CEO
- The Marchesini Group appoints new Sales Director
- Ex-FDA Commissioner joins Pfizer
- Connect 2 Cleanrooms appoints new MD and CEO
- Domain Therapeutics adds Sylvie Ryckebusch to Board
- Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach
- MG America appoints Janice Wortham as Regional Sales Manager
Reports
